LGD SARMS 4033 Australia, which was initially designed to treat muscle wasting disorders such as ageing, osteoporosis, muscular dystrophy, and cancer, is now marketed as a selective non-steroidal anabolic agent.
It is believed to be a chemical that promotes muscle (and bone) development without the negative side effects of steroid usage. However, data on the safety of LGD-4033 is limited due to a lack of medium and long-term clinical trials, therefore the medium and long-term health effects are unclear.
It should be mentioned that a number of SARMs have been linked to health hazards, most notably for the heart and liver.
LGD SARMS 4033 Australia, like other SARMs, is classified as a Schedule 4 medication by the Australian Therapeutic Goods Administration (TGA) — a prescription-only medicine or animal cure. It is prohibited to possess LGD-4033 without the proper authorization.
Athletes are cautioned that LGD-4033 Australia is not only illegal in sports, but it has not yet been cleared via clinical testing.
Background
Concerns regarding the possible negative effects of testosterone on the prostate prompted the development of selective androgen receptor modulators with tissue-specific stimulation of androgenic signalling. LGD-4033 Australia is a new nonsteroidal, oral selective androgen receptor modulator with good affinity and selectivity.
Objective
The purpose of this study was to look at the safety, tolerability, pharmacokinetics, and effects of escalating dosages of LGD SARMS 4033 Australia given daily for 21 days on lean body mass, muscular strength, stair-climbing power, and sex hormones.
Dosage
In this placebo-controlled trial, 76 healthy males (aged 21–50) were randomly assigned to receive placebo or 0.1, 0.3, or 1.0 mg LGD-4033 daily for 21 days. During and after the intervention, blood counts, chemistries, lipids, prostate-specific antigen, ECG, hormones, lean and fat mass and muscular strength were all examined.
Benefits:
Below we present a list of these benefits and the way they boost your training:
Hard Fat Lean Muscle Mass Reconstruction: The application of this SARM has resulted in a wide range of user experiences. Indeed, reports suggest rebuilding lean muscle mass of the order of about 7 kg (i.e. pure muscle) with just 1 cycle of Ligandrol strengthening.
This is correct, since clinical research have confirmed this particular capacity to act in muscle repair.
Even extremely modest (comparison) dosages of SARM Ligandrol LGD-4033 Australia can provide tremendous physical advantages.
Only 2 mg per day are required.
Increase Bone Density/Avoid Fractures: The most dangerous injuries in bodybuilding are to the bones, which are the ones that are most pressured by lifting big loads.
However, an injury is not just a bad as an injury, but also a negative scenario that keeps you out of training and contests for an extended period of time. As we can see, the usage of Ligandrol LGD SARMS 4033 Australia helps enhance the quality of bones and encourages their health.
Faster recovery time allows for more frequent workouts: Another aspect of bodybuilding training that requires special attention is recuperation after a strenuous and exhausting session. After such a rigorous and taxing operation, the body needs some time to “recover” completely.
Failure to comply with recuperation timeframes is usually followed by major injuries. The SARM Ligandrol LGD-4033 shortens the time it takes the body to “recover” after a strenuous activity, allowing for more severe but also more frequent sessions.
Results
- The drug LGD SARMS 4033 Australia was well tolerated. There were no major adverse medication reactions. The frequency of adverse events was comparable in the active and placebo groups.
- At any dose, there was no significant change in haemoglobin, prostate-specific antigen, aspartate aminotransferase, alanine aminotransferase, or QT intervals.
- After multiple dosage, LGD SARMS 4033 Australia demonstrated a lengthy elimination half-life and dose-proportional buildup.
- Total testosterone, sex hormone–binding globulin, high density lipoprotein cholesterol, and triglyceride levels were all reduced by LGD-4033 treatment in a dose-dependent manner. Only the 1.0-mg dosage significantly suppressed follicle-stimulating hormone and free testosterone.
- The amount of lean body mass grew dosage dependently, whereas the amount of fat mass did not alter considerably. After the medication was stopped, hormone levels and cholesterol levels returned to normal.
Final Thoughts:
LGD SARMS 4033 Australia is safe, had a nice pharmacokinetic profile, and increased lean body mass despite no change in prostate-specific antigen over this brief period. Longer randomized studies should be conducted to assess its effectiveness in improving physical function and health outcomes in specific groups.